Vaccination of adolescent girls against human papilloma virus (HPV) appears to have stalled, with only about half of US girls being immunized with at least 1 dose of vaccine by age 17 years.
A recommendation to routinely vaccinate 11- or 12-year-old girls against HPV with 3 doses of vaccine was issued in 2006. Currently available quadrivalent and bivalent vaccines protect against the 2 HPV strains that cause 70% of cervical cancers. The quadrivalent vaccine also protects against 2 other virus strains that cause 90% of genital warts.
HPV Vaccination Appears Stalled. JAMA. 2013;310(11):1114. doi:10.1001/jama.2013.276924
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: